| Product NDC: | 30698-032 |
| Proprietary Name: | Marplan |
| Non Proprietary Name: | isocarboxazid |
| Active Ingredient(s): | 10 mg/1 & nbsp; isocarboxazid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 30698-032 |
| Labeler Name: | Validus Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011961 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19590701 |
| Package NDC: | 30698-032-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (30698-032-01) |
| NDC Code | 30698-032-01 |
| Proprietary Name | Marplan |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (30698-032-01) |
| Product NDC | 30698-032 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | isocarboxazid |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19590701 |
| Marketing Category Name | NDA |
| Labeler Name | Validus Pharmaceuticals LLC |
| Substance Name | ISOCARBOXAZID |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |